Evidence map›Paper›PMID 21076626›Full record

ArticlePlant science : an international journal of experimental plant biology2010

Ectopic expression of rice Xa21 overcomes developmentally controlled resistance to Xanthomonas oryzae pv. oryzae.

Chang-Jin Park, Sang-Won Lee, Mawsheng Chern, Rita Sharma, Patrick E Canlas, Min-Young Song, Jong-Seong Jeon, Pamela C Ronald

Open access · greenAbstract read
In one paragraph

Article in Plant science : an international journal of experimental plant biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Research Progress on Cloning and Function ofFrontiers in plant science · 2022
    Review
  7. Frontiers in plant science · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Chang-Jin ParkDepartment of Plant Pathology, University of California Davis, Davis, California, United States of America.
Sang-Won Lee
Mawsheng Chern
Rita Sharma
Patrick E Canlas
Min-Young Song
Jong-Seong Jeon
Pamela C Ronald
University of California, Davis · USKyung Hee University · KR

Funding

Receptor Kinase-Mediated Signaling in the Innate Immune ResponseR01GM055962 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI RONALD, PAMELA C · 1999 to 2013
$2.9M
NIGMS NIH HHS R01 GM055962
6 · The paper itself

Abstract

Recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs) activates the innate immune response. The rice PRR, XA21, confers robust resistance at adult stages to most strains of the bacterial pathogen Xanthomonas oryzae pv. oryzae (Xoo). Seedlings are still easily infected by Xoo, causing severe yield losses. Here we report that Xa21 is induced by Xoo infection and that ectopic expression of Xa21 confers resistance at three leaf stage (three-week-old), overcoming the developmental limitation of XA21-mediated resistance. Ectopic expression of Xa21 also up-regulates a larger set of defense-related genes as compared to Xa21 driven by the native promoter. These results indicate that altered regulation of Xa21 expression is useful for developing enhanced resistance to Xoo at multiple developmental stages.

Indexed as

Oryza sativapathogen-associated molecular patternpattern recognition receptorXA21Xanthomonas oryzae pv. oryzae

Identifiers

PMID21076626
PMCPMC2976559
OpenAlexW2114883879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.